| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| Gene symbol | EGFR | Synonyms | ERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7p11.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | epidermal growth factor receptor | ||||
| GTO ID | GTC3002 |
| Trial ID | NCT05341492 |
| Disease | Triple-Receptor Negative Breast Cancer | Lung Cancer |
| Altered gene | EGFR|CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EGFR/B7-H3 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer |
| Year | 2022 |
| Country | China |
| Company sponsor | Second Affiliated Hospital of Guangzhou Medical University |
| Other ID(s) | ZZBGCART-016 |
| Cohort 1 | |||||||||
|
|||||||||